FDA Approves Two Drugs to Treat Coronavirus, 15-Minute Test

In addition to the search for a vaccine, drug companies are working to find effective treatments to reduce coronavirus symptoms and potentially prevent hospitalization. This week, pharmaceutical company Eli Lilly announced a breakthrough in their antibody research, as well as a potential treatment option with a drug commonly used to treat rheumatoid arthritis. For the latest from Eli Lilly, we spoke to Andrew Adams, Vice President of New Therapeutic Modalities and COVID-19 research at Eli Lilly.

This week pharmaceutical company Moderna said the company should know if its vaccine candidate works by November. As we know, Astrazeneca and Pfizer are also working on vaccine candidates in late stage trials. For more on the latest vaccine news, we spoke to Doctor Daniel B. Fagbuyi, Obama administration biodefense expert & ER physician.

As pharmaceutical companies face mounting pressure to create an effective COVID-19 vaccine, we're taking a look at the time it takes to develop one, run it through several trials of testing, and come up with a final product. Cheddar's Azia Celestino and Kristen Scholer report.